Abstract:
The present invention relates to preservative compositions for the formulation of cosmetics such as personal care products and skin and scalp care products. The composition exerts a preservative action without significantly changing the balance of the microbiota of an individual's skin, when applied to the skin.
Abstract:
An ophthalmic composition containing a linear polymer such as hyaluronic acid optionally in the form of salt, a branched polymer such as xanthan gum optionally in the form of salt in combination with at least one osmoprotector, is provided herein. The composition of the invention finds application in the treatment of eye diseases.
Abstract:
The invention relates to selected peptides which repair, by means of nucleotide excision repair (NER), cellular DNA damaged by the exposure to external agents in particular UV rays and the cosmetic or pharmaceutical use thereof in skin treatment. The invention also relates to compositions for topical application containing the peptides preferably carried in liposomes to prevent and treat skin damage caused by the exposure to UV rays in particular in subjects affected by xeroderma pigmentosum.
Abstract:
The present invention relates to the use of a plant extract from the genus Galeopsis species tetrahit or a composition that contains it to stimulate hair growth or improve the appearance or hair fullness. The composition containing the plant extract is applied in both cosmetic and medical-trichological fields and can be applied topically on the scalp or administered orally.
Abstract:
The present invention relates to a method and an apparatus for producing an embossing on a substrate by means of digital printing technology. The method provides for the application of an embossing liquid, for example water- based, on a non-polymerized resin layer and the following polymerization of the resin by means of UV curing.
Abstract:
The present application describes compositions that can be used for the controlled release of pharmacological active ingredients from a viscoelastic aqueous polysaccharide matrix, and their potential use in the treatment of different stages of musculoskeletal diseases. The combination of drug release modulation and the viscoelastic nature of the composition makes possible the use thereof in the treatment of acute and chronic phases of musculoskeletal diseases characterized by an inflammatory state, and where a therapeutic effect and a viscosupplemental contribution are required.
Abstract:
The present application describes polysaccharide compositions that can be used as modulators of cell proliferation processes and their use in tissue repair with fibrotic process inhibition. These modulation properties can be usefully used in tissue repair for the prevention of fibrotic processes and/or tissue adhesions in traumatic, post-surgical and chronic fibrotic processes associated to autoimmune diseases.
Abstract:
The present invention relates to a selected amide of γ-hydroxybutyric acid, a process of manufacture and uses thereof. The invention also includes a pharmaceutical composition comprising an effective amount of the selected compound of the invention for use in preventing or treating drug addiction, especially alcohol misuse or dependency.
Abstract:
The present invention relates to a filler and a filler composition based on polynucleotides comprising a nucleic acid polymer chain moiety with a molecular weight distribution from 0.5 to 3000 kDalton, the nucleic acid polymer chain moiety is at least partially crosslinked with a biocompatible crosslinking agent. The filler is applied for aesthetic purposes, in particular to increase the volume of areas of the body or to smooth wrinkles, furrows, skin folds, in particular localized on the face and for orthopedic applications. The progressive hydrolysis of free nucleotides allows the activation of their trophic effect on the tissues, integrating the filler effect with the tissue trophic effect.
Abstract:
The present invention relates to polyglycerol-azelaic acid polyesters and cosmetic compositions that incorporate them as active components in combination with a cosmetically acceptable vehicle. In certain aspects the invention also relates to a process for producing esters and polyesters between azelaic acid and glycerol or oligomers thereof containing up to 10 monomer units.